Association of Angiotensin II Type 1 Receptor Agonistic Autoantibodies With Outcomes in Patients With Acute Aortic Dissection

被引:5
|
作者
Wu, Xiao-wei [1 ]
Li, Gang [2 ,3 ]
Cheng, Xiao-bin [2 ]
Wang, Min [2 ]
Wang, Liu-lin [2 ]
Wang, Hai-hao [4 ]
Yang, Jian-ye [4 ]
Hu, Xing-jian [5 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Thorac Surg, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
[2] Hubei Prov Hosp Tradit Chinese Med, Emergency Dept, 856 Luoyu Rd, Wuhan 430061, Peoples R China
[3] Hubei Prov Acad Tradit Chinese Med, Wuhan, Peoples R China
[4] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiothorac & Vasc Surg, Tongji Hosp, Wuhan, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Cardiovasc Surg, Wuhan, Peoples R China
关键词
RISK; AT(1); SENSITIVITY; BIOMARKERS; ANTIBODIES; MANAGEMENT;
D O I
10.1001/jamanetworkopen.2021.27587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Angiotensin II is significantly associated with the pathogenesis of acute aortic dissection. Angiotensin II type 1 receptor agonistic autoantibodies (AT1-AAs) can mimic the effect of angiotensin II. OBJECTIVE To investigate the association between AT1-AAs and all-cause and cause-specific mortality risk in patients with acute aortic dissection. DESIGN, SETTING, AND PARTICIPANTS A total of 662 patients with clinically suspected aortic dissection from 3 medical centers inWuhan, China, were enrolled in this cohort study from August 1, 2014, to July 31, 2016. Of these, 315 patients were included in the 3-year follow-up study. Follow-up was mainly performed via telephone interviews and outpatient clinic visits. Data analysis was conducted from March 1 toMay 31, 2020. MAIN OUTCOMES AND MEASURES The primary outcomes of interest were all-cause mortality, death due to aortic dissection, and late aortic-related adverse events. RESULTS The full study cohort included 315 patients with AAD (mean [SD] age, 56.2 [12.7] years; 230 men [73.0%]). Ninety-two patients (29.2%) were positive for AT1-AAs. The mortality of AT1-AA-positive patients was significantly higher than that of AT1-AA-negative patients (40 [43.5%] vs 37 [16.6%]; P <.001). The mortality risk in AT1-AA-positive patients was always significantly higher than that in AT1-AA-negative patients in patients with both type A and type B dissection. Multivariable analysis showed that the risk of AT1-AA-positive patients for type A dissection was significantly higher than that of AT1-AA-negative patients (odds ratio [OR], 1.88; 95% CI, 1.12-3.13; P =.02). The Cox proportional hazards regression model showed a significant increase of all-cause mortality risk (OR, 2.27; 95% CI, 1.44-3.57; P <.001) and late aortic-related adverse events (OR, 1.58; 95% CI, 1.062.36; P =.03) among AT1-AA-positive patients during the follow-up period compared with AT1-AA-negative patients. CONCLUSIONS AND RELEVANCE This cohort study first detected AT1-AAs in patients with acute aortic dissection. The presence of AT1-AAs was associated with significantly higher all-cause and cause-specific mortality during a follow-up period of 3 years. The antibodiesmay be a risk factor for aortic dissection.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction
    Tona, Francesco
    Civieri, Giovanni
    Vadori, Marta
    Masiero, Giulia
    Iop, Laura
    Marra, Martina Perazzolo
    Perin, Valentina
    Cuciz, Elisa
    Cecere, Annagrazia
    Bernava, Giacomo
    Tansella, Donatella
    Naumova, Nataliia
    Grewal, Simran
    Cozzi, Emanuele
    Iliceto, Sabino
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (04):
  • [2] Agonistic autoantibodies to the angiotensin II type 1 receptor increase endothelial cell sensitivity to angiotensin II.
    LaMarca, Babbette
    Roberts, Lyndsay
    Dechend, Ralf
    HYPERTENSION, 2007, 50 (04) : E149 - E149
  • [3] Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia
    Hubel, Carl A.
    Wallukat, Gerd
    Wolf, Myles
    Herse, Florian
    Rajakumar, Augustine
    Roberts, James M.
    Markovic, Nina
    Thadhani, Ravi
    Luft, Friedrich C.
    Dechend, Ralf
    HYPERTENSION, 2007, 49 (03) : 612 - 617
  • [4] The agonistic autoantibodies to the angiotensin II type 1 receptor in pregnancies complicated by hypertensive disorders
    Szpera-Gozdziewicz, Agata
    Gozdziewicz, Tomasz
    Wirstlein, Przemyslaw
    Wender-Ozegowska, Ewa
    Breborowicz, Grzegorz H.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (07): : 1219 - 1223
  • [5] Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia
    Wallukat, G
    Neichel, D
    Nissen, E
    Homuth, V
    Luft, F
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (02) : 79 - 83
  • [6] Agonistic autoantibodies to the angiotensin II type 1 receptor increases Angiotensin II-induced ET-1 production
    Roberts, Lyndsay
    Dukes, Matthew P.
    Fournier, Lillian
    Dechend, Ralf
    Wallukat, Gerd
    LaMarca, Babbette
    FASEB JOURNAL, 2008, 22
  • [7] Angiotensin-II receptor type 1 and endothelin-1 receptor type A agonistic autoantibodies in patients with STEMI: new kids on the block
    Civieri, G.
    Martini, M.
    Masiero, G.
    Schiavon, B.
    Bernava, G.
    Vadori, M.
    Iop, L.
    Marra, M. Perazzolo
    Cecere, A.
    Leoni, L.
    Cozzi, E.
    Iliceto, S.
    Tona, F.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [8] Role of angiotensin II type I receptor agonistic autoantibodies (AT1-AA) in preeclampsia
    LaMarca, Babbette
    Wallace, Kedra
    Granger, Joey
    CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (02) : 175 - 179
  • [9] Role of agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) in pathogenesis of preeclampsia
    Wang, Jing
    Shan, Lijuan
    Zhao, Yanhui
    Cao, Hongwen
    Lan, Shuhai
    Yan, Yizi
    GLOBAL MEDICAL GENETICS, 2025, 12 (02):
  • [10] The Role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeciampsia
    Campbell, Nathan
    LaMarca, Babbette
    Cunningham, Mark W., Jr.
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2018, 19 (10) : 781 - 785